Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
ACCENTIA BIOPHARMACEUTICALS INC (ABPI)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 | Sep-30-08 | Sep-30-07 | Sep-30-06 | Sep-30-05 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 5.9 | 5.2 | 6.3 | 14.0 | 9.2 | 5.8 | 11.2 | 10.1 |
| Asset turnover | 1.0 | 0.7 | 0.8 | 0.8 | 0.6 | 0.3 | 0.6 | 1.6 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | | | | | | | -2525.3% | |
| ROIC (including intangibles) | 95.2% | 380.1% | -331.6% | -318.1% | 77.8% | 162.7% | -62.4% | 86.8% |
| ROE | 9.6% | 24.1% | 2.2% | 7.1% | 33.8% | 65.3% | -50.0% | 61.3% |
| ROA | -297.5% | -354.9% | -64.1% | -78.6% | -138.3% | -118.8% | -50.0% | -228.9% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 19.9 | 122.0 | 87.7 | 100.8 | 107.9 | 108.7 | 15.8 | 0.0 |
| Days payables outstanding | 155.0 | 126.6 | | 71.3 | 397.0 | 552.0 | | 244.7 |
| Days inventory outstanding | 52.7 | 78.0 | 52.5 | 23.7 | 38.7 | 62.6 | 65.3 | |
| Cash conversion cycle | -82.4 | 73.5 | 140.2 | 53.2 | -222.2 | -380.7 | 81.1 | -244.7 |
|